Quick Answer
Health In Tech, Inc. reported Research And Development Expense of $1.57 million for the year ending 2025.
- Health In Tech, Inc. showed a decrease of -44.2% in Research And Development Expense from 2024 to 2025.
- This data is from Health In Tech, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $760.2 thousand | Q2 2024: $701.6 thousand | Q3 2024: $718.4 thousand | Q1 2025: $537.7 thousand | Q2 2025: $582.6 thousand | Q3 2025: $235.8 thousand.
- Over the full 3 years of available data (2023 to 2025), Health In Tech, Inc.'s Research And Development Expense has declined by 21.7%.
- Historical annual values: Fiscal year 2025: $1.57 million | Fiscal year 2024: $2.81 million | Fiscal year 2023: $2.00 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: